American Journal of Kidney Diseases
Volume 52, Issue 4 , Pages 727-736, October 2008

Erythropoietin, Iron Depletion, and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in Hemodialysis

  • Elani Streja, MPH

      Affiliations

    • Harold Simmons Center for Kidney Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
    • Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA
    • ,
  • Csaba P. Kovesdy, MD

      Affiliations

    • Salem VA Medical Center, Salem, VA
    • ,
  • Sander Greenland, DrPH

      Affiliations

    • Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA
    • ,
  • Joel D. Kopple, MD

      Affiliations

    • Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
    • David Geffen School of Medicine at UCLA, Los Angeles, CA
    • Department of Family Health, UCLA School of Public Health, Los Angeles, CA
    • ,
  • Charles J. McAllister, MD

      Affiliations

    • DaVita, Inc, El Segundo, Los Angeles, CA
    • ,
  • Allen R. Nissenson, MD

      Affiliations

    • David Geffen School of Medicine at UCLA, Los Angeles, CA
    • Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA
    • ,
  • Kamyar Kalantar-Zadeh, MD, MPH, PhD

      Affiliations

    • Harold Simmons Center for Kidney Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
    • Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA
    • Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
    • David Geffen School of Medicine at UCLA, Los Angeles, CA
    • Corresponding Author InformationAddress correspondence to Kamyar Kalantar-Zadeh, MD, MPH, PhD, Harold Simmons Center for Kidney Disease Research and Epidemiology, LABioMed at Harbor-UCLA Medical Center, 1124 West Carson St, C1-Annex, Torrance, CA 90509-2910

Received 17 January 2008; accepted 12 May 2008. published online 01 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2008.05.029 on September 2, 2008.

PII: S0272-6386(08)01005-6

doi:10.1053/j.ajkd.2008.05.029

Refers to article:

  • Normalization of Hemoglobin in Patients With CKD May Cause Harm: But What Is the Mechanism?

    T.J. Littlewood
    American Journal of Kidney Diseases October 2008 (Vol. 52, Issue 4, Pages 642-644)

American Journal of Kidney Diseases
Volume 52, Issue 4 , Pages 727-736, October 2008

Article Tools

* Image Usage & Resolution